pantoprazole has been researched along with Chemical Dependence in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"To quantify the effect of blinded dosage reduction after long-term therapy on symptom control and quality of life while assessing pharmacological and placebo needs." | 2.75 | Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial. ( de Wit, NJ; Grobbee, DE; Numans, ME; Quartero, AO; van der Velden, AW, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
van der Velden, AW | 1 |
de Wit, NJ | 1 |
Quartero, AO | 1 |
Grobbee, DE | 1 |
Numans, ME | 1 |
1 trial available for pantoprazole and Chemical Dependence
Article | Year |
---|---|
Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug | 2010 |